These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33870052)

  • 1. Open Science for private Interests? How the Logic of Open Science Contributes to the Commercialization of Research.
    Fernández Pinto M
    Front Res Metr Anal; 2020; 5():588331. PubMed ID: 33870052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OECD guidelines on open access: commercialization in disguise?
    Hoeyer K; Svendsen MN; Koch L
    Trends Biotechnol; 2008 Sep; 26(9):479-82. PubMed ID: 18684538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donors, authors, and owners: how is genomic citizen science addressing interests in research outputs?
    Guerrini CJ; Lewellyn M; Majumder MA; Trejo M; Canfield I; McGuire AL
    BMC Med Ethics; 2019 Nov; 20(1):84. PubMed ID: 31752834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare.
    Moynihan R; Fabbri A; Parker L; Bero L
    BMJ Open; 2020 May; 10(5):e034195. PubMed ID: 32393611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The science commons in health research: structure, function, and value.
    Cook-Deegan R
    J Technol Transf; 2007; 32(3):133-156. PubMed ID: 27570367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The commercialization of the biomedical sciences: (mis)understanding bias.
    de Melo-Martín I
    Hist Philos Life Sci; 2019 Sep; 41(3):34. PubMed ID: 31485872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual property and the commercialization of research and development.
    di Norcia V
    Sci Eng Ethics; 2005 Apr; 11(2):203-19. PubMed ID: 15915860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open science versus commercialization: a modern research conflict?
    Caulfield T; Harmon SH; Joly Y
    Genome Med; 2012 Feb; 4(2):17. PubMed ID: 22369790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reconceptualising the meaning of scientific communication: open access].
    Guédon JC
    Med Sci (Paris); 2008; 24(6-7):641-5. PubMed ID: 18601883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining responsible research and innovation for the advancement of biobanking and biomedical research.
    Yu H
    J Law Biosci; 2016 Dec; 3(3):611-635. PubMed ID: 28852540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Core Roles of Transparency and Accountability in the Governance of Global Health Public-Private Partnerships.
    Reich MR
    Health Syst Reform; 2018; 4(3):239-248. PubMed ID: 30207904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to reduce corruption in the health sector.
    Gaitonde R; Oxman AD; Okebukola PO; Rada G
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008856. PubMed ID: 27528494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis.
    Yeung AWK; Atanasov AG; Sheridan H; Klager E; Eibensteiner F; Völkl-Kernsock S; Kletecka-Pulker M; Willschke H; Schaden E
    Front Pharmacol; 2020; 11():587526. PubMed ID: 33519448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific journals and their authors' financial interests: a pilot study.
    Krimsky S; Rothenberg LS; Stott P; Kyle G
    Psychother Psychosom; 1998; 67(4-5):194-201. PubMed ID: 9693346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental justice, values, and scientific expertise.
    Steel D; Whyte KP
    Kennedy Inst Ethics J; 2012 Jun; 22(2):163-82. PubMed ID: 23002582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Product Development and Commercialization of Diagnostic or Life Science Products for Scientists and Researchers.
    Alonso MM
    Methods Mol Biol; 2017; 1606():399-407. PubMed ID: 28502015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are industry-funded charities promoting "advocacy-led studies" or "evidence-based science"?: a case study of the International Life Sciences Institute.
    Steele S; Ruskin G; Sarcevic L; McKee M; Stuckler D
    Global Health; 2019 Jun; 15(1):36. PubMed ID: 31155001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.
    Gibson SG; Axler RE; Lemmens T
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):310-325. PubMed ID: 28818009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Private interests count too: commentary on "Science, democracy, and the right to research".
    Frankel MS
    Sci Eng Ethics; 2009 Sep; 15(3):367-73. PubMed ID: 19449130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.